Fondaparinux overdosage: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Fondaparinux}} {{CMG}}; {{AE}} {{AZ}} ==Overdosage== *There is no known antidote for ARIXTRA. Overdose of ARIXTRA may lead to hemorrhagic complications. *'''Di..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
==Overdosage== | ==Overdosage== | ||
*There is no known antidote for ARIXTRA. Overdose of ARIXTRA may lead to hemorrhagic complications. | *There is no known antidote for ARIXTRA. Overdose of ARIXTRA may lead to hemorrhagic complications. | ||
*'''Discontinue treatment and initiate appropriate therapy if bleeding complications associated with overdosage occur'''. | *'''Discontinue treatment and initiate appropriate therapy if bleeding complications associated with overdosage occur'''. | ||
*Data obtained in patients undergoing chronic intermittent hemodialysis suggest that clearance of ARIXTRA can increase by 20% during [[hemodialysis]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARIXTRA (FONDAPARINUX SODIUM) INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05bb2dd4-5fb5-4ec9-29a8-d200e62d1a8f | publisher = | date = | accessdate = }}</ref> | |||
*Data obtained in patients undergoing chronic intermittent hemodialysis suggest that clearance of ARIXTRA can increase by 20% during [[hemodialysis]]. | |||
==References== | ==References== |
Revision as of 23:36, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overdosage
- There is no known antidote for ARIXTRA. Overdose of ARIXTRA may lead to hemorrhagic complications.
- Discontinue treatment and initiate appropriate therapy if bleeding complications associated with overdosage occur.
- Data obtained in patients undergoing chronic intermittent hemodialysis suggest that clearance of ARIXTRA can increase by 20% during hemodialysis.[1]
References
Adapted from the FDA Package Insert.